1,775 Shares in Danaher Corporation $DHR Bought by Jackson Thornton Wealth Management LLC

Jackson Thornton Wealth Management LLC bought a new position in Danaher Corporation (NYSE:DHRFree Report) in the 2nd quarter, HoldingsChannel.com reports. The firm bought 1,775 shares of the conglomerate’s stock, valued at approximately $356,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Hills Bank & Trust Co lifted its position in Danaher by 0.3% in the first quarter. Hills Bank & Trust Co now owns 18,015 shares of the conglomerate’s stock worth $3,693,000 after purchasing an additional 53 shares during the period. Worth Financial Advisory Group LLC lifted its holdings in shares of Danaher by 4.6% during the second quarter. Worth Financial Advisory Group LLC now owns 1,195 shares of the conglomerate’s stock valued at $236,000 after acquiring an additional 53 shares during the period. Sageworth Trust Co lifted its holdings in shares of Danaher by 2.3% during the first quarter. Sageworth Trust Co now owns 2,404 shares of the conglomerate’s stock valued at $493,000 after acquiring an additional 54 shares during the period. 1834 Investment Advisors Co. lifted its holdings in shares of Danaher by 3.3% during the first quarter. 1834 Investment Advisors Co. now owns 1,666 shares of the conglomerate’s stock valued at $342,000 after acquiring an additional 54 shares during the period. Finally, Bruce G. Allen Investments LLC lifted its holdings in shares of Danaher by 13.1% during the second quarter. Bruce G. Allen Investments LLC now owns 467 shares of the conglomerate’s stock valued at $92,000 after acquiring an additional 54 shares during the period. 79.05% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on DHR. Rothschild & Co Redburn reissued a “neutral” rating and set a $220.00 price objective (down from $245.00) on shares of Danaher in a report on Wednesday, October 8th. Robert W. Baird lifted their price objective on Danaher from $229.00 to $236.00 and gave the company an “outperform” rating in a report on Wednesday, October 15th. Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a report on Friday, June 27th. Barclays reissued an “overweight” rating and set a $225.00 price objective (up from $215.00) on shares of Danaher in a report on Tuesday, June 24th. Finally, UBS Group cut their price objective on Danaher from $240.00 to $225.00 and set a “buy” rating for the company in a report on Wednesday, July 23rd. Seventeen analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $245.00.

Read Our Latest Research Report on Danaher

Insider Buying and Selling

In related news, Director Teri List sold 2,778 shares of Danaher stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares in the company, valued at $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 11.20% of the stock is currently owned by insiders.

Danaher Price Performance

Shares of DHR stock opened at $208.06 on Tuesday. The stock has a 50-day moving average price of $201.76 and a 200 day moving average price of $197.42. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The firm has a market cap of $148.98 billion, a price-to-earnings ratio of 44.27, a PEG ratio of 2.98 and a beta of 0.77. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $274.21.

Danaher (NYSE:DHRGet Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping analysts’ consensus estimates of $1.64 by $0.16. The firm had revenue of $5.94 billion during the quarter, compared to analyst estimates of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company’s revenue was up 3.4% on a year-over-year basis. During the same period last year, the company earned $1.72 earnings per share. Research analysts expect that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be given a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher’s dividend payout ratio (DPR) is presently 27.23%.

Danaher Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.